Las Vegas, NV -- (SBWIRE) -- 12/11/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Vical Incorporated (NASDAQ:VICL), RadioShack Corporation (NYSE:RSH),Northwest Biotherapeutics, Inc (NASDAQ:NWBO), Trunkbow International Holdings Ltd (NASDAQ:TBOW)
Vical Incorporated (NASDAQ:VICL) managed to keep its fall at -0.91% on above-normal volume of 1.60M shares. The stock settled at $1.09 after floating in a range of $1.09 to $1.12. Its latest price has reached market capitalization of $94.59 million. Its 52-week range has been $1.07 to $4.51. Vical Incorporated researches and develops biopharmaceutical products based on its deoxyribonucleic acid (DNA) delivery technologies for the prevention and treatment of serious or life-threatening diseases. The Company has three active independent clinical and preclinical development programs in the areas of infectious disease and cancer, including a fully enrolled Phase III clinical trial using its Allovectin immunotherapeutic in patients with metastatic melanoma; a completed preclinical program, with an allowed investigational new drug application.
Has VICL Found The Bottom and Ready To Move Up? Find Out Here
RadioShack Corporation (NYSE:RSH) traded down on a volume of 1.54 million, lower than its standard daily volume. Shares have dropped-1.03% to $2.87. Over the last twelve months, the stock has gained 47.18% and faced a worst price of $1.94. RadioShack Corporation (RadioShack) is engaged in the retail sale of consumer electronics goods and services through its RadioShack store chain. The Company’ segments include U.S. Radioshack Company-Operated Stores and Others. As of December 31, 2012, the Company operated 4,395 U.S. company-operated stores under the RadioShack brand located throughout the United States, as well as in Puerto Rico and the U.S. Virgin Islands. These stores are located in strip centers and major shopping malls, as well as individual storefronts.
Has RSH Found The Bottom And Ready To Gain Momentum? Find Out Here
Northwest Biotherapeutics, Inc (NASDAQ:NWBO) settled -6.14% lower at $4.13 on below -normal volume of 1.38M shares during the last trading day. The stock has its 12-month high at $6.89 and 52-week low price was $2.98. It traded in a range of $4.06 to $4.75 during the last trading day. Northwest Biotherapeutics, Inc. is a development-stage company. The Company focuses on discovering, developing, and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. The Company's approach in developing cancer therapies utilizes its capability in the biology of dendritic cells (DC), which are a type of white blood cells that activate the immune system. It focused on advancing a dendritic cell immunotherapy for prostate and brain cancer.
Will NWBO Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, Trunkbow International Holdings Ltd (NASDAQ:TBOW) was up on high volume, trading at a volume of 1.36M versus its average daily volume of 67,928.00 shares. At $1.33, the stock has attained market capitalization of 48.95 million. Trunkbow International Holdings Limited (Trunkbow), is a mobile application enabler, offering telecom operators in China with application platforms, on which to offer Mobile Value Added Solutions (MVAS) to subscribers. The Company develops and implement a range of platform solutions for its customers that enables MVAS applications for their subscribers. Trunkbow's solutions are generally classified into two categories: MVAS Technology Platforms and Mobile Payment Solutions. It provides both hardware and software solutions that are integrated into its clients’ existing information technology (IT) infrastructure.
Will TBOW Continue To Move Higher? Find Out Here
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimer at: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)